
zzso is an epidemic with tremendous impact on both patients and health-care systems zzso This paper explores some of the questions related to the clinical development of new zzso in the context of an evolving regulatory zzso These include patient entry criteria, clinical database size, study designs, weight loss end points (including those for maintenance of weight loss and prevention of weight zzso clinically important zzso zzso zzso factor end points, and challenges in establishing safety and efficacy in zzso patients, and approaches to the development of combination zzso Ultimately, patients, physicians, academia, industry, zzso and governments must continue to partner with regulators to help establish the appropriate balance between the known adverse consequences associated with inadequate treatment of the growing obesity epidemic and the concern for potential unknown risks that may be associated with the long-term use of new zzso 

